4
Changes in Ownership
Cabaletta Bio, Inc. Filed Acc 0000950170-23-065521
See Remarks sold 11,000 shares at an average $17.82 ($196,014)
- See Remarks acquired 11,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Binder Gwendolyn See Remarks | 2023-11-20 | Option exercise | +11,000 | $1.01 | $11,110 | 31,000 | D: show line 1 in the form |
| Binder Gwendolyn See Remarks | 2023-11-20 | Sale | −3,542 | $17.39 | $61,608 | 27,458 | D: show line 2 in the form |
| Binder Gwendolyn See Remarks | 2023-11-20 | Sale | −7,458 | $18.02 | $134,405 | 20,000 | D: show line 3 in the form |
| Open-market sales · 11,000 sh · avg $17.82 · $196,014 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Binder Gwendolyn See Remarks | 2023-11-20 | Option exercise · Stock Option (Right to Buy) | −11,000 | 122,756 | D: show line 4 in the form |
Loading xslF345X05/ownership.xml…